-
1
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
Published 2025-01-01Subjects: Get full text
Article -
2
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them
Published 2025-02-01Subjects: Get full text
Article -
3
-
4
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer
Published 2025-01-01Subjects: Get full text
Article -
5
Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors
Published 2023-12-01Subjects: Get full text
Article -
6
Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study
Published 2025-01-01Subjects: Get full text
Article -
7
Systematic Review and Network Meta-Analysis on Treating Hormone Receptor-Positive Metastatic Breast Cancer After CDK4/6 Inhibitors
Published 2025-01-01Subjects: Get full text
Article